Dr. Hamid R. Mirshahidi, MD

  • Loma Linda, CA
  • Medical oncologist
NPI1659307015PAC ID2769418664
Medicare services, 2024
979
Medicare patients, 2024
234
Part D claims, 2024
668
Publications
38
Clinical trials
8
Practice address
11234 Anderson St, Loma Linda, CA 92354
Practice phone
Call (909) 558-4000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Loma Linda University Medical Center

Hospital · Loma Linda, California

See all 3 affiliations

Find Dr. Mirshahidi's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Hamid R. Mirshahidi is a medical oncologist in Loma Linda, California

Dr. Mirshahidi practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Dr. Mirshahidi's NPI, 1659307015, was assigned on June 25, 2006. Dr. Mirshahidi graduated from Marmara Univ- Fac Med in 1992. Dr. Mirshahidi holds California license A80969.

NPI and contact details
Medicare PAC ID
2769418664
NPI enumeration date
June 25, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(909) 558-4000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
60
Medical school graduation
1992

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Hamid R. Mirshahidi practices at Loma Linda University Medical Center in Loma Linda, California

Dr. Mirshahidi's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Source: Dmand AI Affiliation Data

Dr. Hamid R. Mirshahidi is affiliated with 2 sites of care and 1 medical group

Dr. Mirshahidi's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Mirshahidi to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Mirshahidi

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Hamid R. Mirshahidi's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirshahidi practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Loma Linda University Medical CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Mirshahidi practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Seventh-day Adventist Church and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Hamid R. Mirshahidi is one of 415 medical oncologists in California

Medical oncology is Dr. Mirshahidi's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mirshahidi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Mirshahidi's licenses on file in 3 states: California, Michigan and West Virginia.

Specialties and state licenses

  • Medical oncology, CaliforniaPrimaryLicense A80969 · 2002 to 2026 · taxonomy 207RX0202X
  • Michigan license1999 to 2018
  • West Virginia license2002 to 2017

Clinical focus

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Mirshahidi treats.

Medical oncologists near Dr. Mirshahidi

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Hamid R. Mirshahidi billed Medicare for 979 services in 2024

CMS data shows 979 Medicare services from Dr. Mirshahidi across 6 procedure codes in 2024, for 234 Medicare patients. Medicare paid $48,076 for them.

Medicare services, 2024979
Medicare patients234
Paid by Medicare$48,076
Procedure codes6

Dr. Mirshahidi's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 5962024: 5813%
Other services
2023: 02024: 398

Where Dr. Mirshahidi's Medicare services took place, 2024

  • In an office333%
  • In a facility94697%

Dr. Mirshahidi compared with the California median for medical oncologists, 2024

  • Dr. Mirshahidi
  • California median
Medicare services
979vs 49697% above
Medicare patients
234vs 15452% above
Part D claims
526vs 1443.7 times

Medians across 358 medical oncologists in California with Dmand AI profiles that report each measure.

Dr. Mirshahidi's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mirshahidi

Need commercial claims for Dr. Mirshahidi?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mirshahidi and other medical oncologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Hamid R. Mirshahidi treated 234 Medicare patients in 2024, average age 72

CMS counts 234 Medicare patients who saw Dr. Mirshahidi in 2024. The largest group is 65 to 74, with 108 patients. 73% of them have high blood pressure, and 72% have cancer. 38% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mirshahidi's median patient age at 67, with 66% women.

Medicare patients, 2024234
Average age72
Average risk score2.46
Also on Medicaid38%

Dr. Mirshahidi's Medicare patients by age, 2024

Dr. Mirshahidi's Medicare patients by sex, 2024

  • Women15767%
  • Men7733%

Chronic conditions among Dr. Mirshahidi's Medicare patients, 2024

  1. High blood pressure73%
  2. Cancer72%
  3. High cholesterol65%
  4. Arthritis45%
  5. Diabetes39%
  6. Chronic kidney disease28%
  7. COPD26%
  8. Ischemic heart disease26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mirshahidi's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women66%
  • Men33%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Hamid R. Mirshahidi wrote 668 Medicare Part D claims in 2024

In 2024, Dr. Mirshahidi wrote 668 Medicare Part D claims for 116 patients. 74% of them were for generic drugs. CMS names the drug for 526 of them, across 16 drugs with 11 or more claims each, at $1,825,681 in total drug cost. In 2023, CMS named 454 claims across 10 drugs.

Part D claims, 2024668
Drugs named by CMS16
Total drug cost$1.8M
Part D patients116

Dr. Mirshahidi's Part D claims by kind of drug, 2024

  • Generic497 claims74%
  • Brand-name171 claims26%

Dr. Mirshahidi's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Mirshahidi's Part D claims, 2024

  • Antibiotics2%15 of 668 claims
  • Antipsychotics, patients 65 and over2%14 of 668 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4542024: 52616%

Drugs named by CMS: 16 in 2024, 10 in 2023.

See all prescribing by Dr. Mirshahidi

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Hamid R. Mirshahidi scored 89 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Mirshahidi for performance year 2024, reported as part of a group. Dr. Mirshahidi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mirshahidi as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Mirshahidi's MIPS scores, performance year 2024

  • 89of 100Final score
  • 72.1of 100Quality
  • 80of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 77of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Mirshahidi by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Hamid R. Mirshahidi has 38 publications on record

Dmand AI links 38 papers to Dr. Mirshahidi, published from 2010 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Lung Neoplasms. Dr. Mirshahidi has published most often in Exp Hematol Oncol. Dr. Mirshahidi's most frequent co-authors are Anthony Loc Nguyen, MD, David Baylink, MD and Joel M. Brothers, MD.

Papers38
Years published2010 to 2025

Dr. Mirshahidi's papers by year, 2010 to 2025

Topics Dr. Mirshahidi writes about most

  • Breast Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Protein Kinase Inhibitors
  • Anaplastic Lymphoma Kinase
  • Disease Progression

Dr. Mirshahidi's most frequent co-authors

Recent publications by Dr. Mirshahidi

See all 38 publications and co-authors

See who Dr. Mirshahidi researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mirshahidi works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Hamid R. Mirshahidi has worked on 8 clinical trials

Dmand AI links Dr. Mirshahidi to 8 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Small Cell Lung Carcinoma, Carcinoma, Bronchogenic and Carcinoma, Non-Small-Cell Lung. SWOG Cancer Research Network sponsors the most, 5.

Clinical trials with Dr. Mirshahidi by phase

  1. NonePhase 1: no trials
  2. 1Phase 1/2: 1 trial
  3. 2Phase 2: 2 trials
  4. 1Phase 2/3: 1 trial
  5. 1Phase 3: 1 trial
  6. NonePhase 4: no trials

Conditions in Dr. Mirshahidi's trials

  • Small Cell Lung Carcinoma
  • Carcinoma, Bronchogenic
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Small Cell
  • Carcinoma, Neuroendocrine

Investigators on the most trials with Dr. Mirshahidi

Recent clinical trials with Dr. Mirshahidi

See all 8 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Hamid R. Mirshahidi received $81,817 in industry payments from 2016 to 2025

CMS Open Payments shows 127 general payments to Dr. Mirshahidi from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Merck Sharp & Dohme Corporation paid the most, $47,992. It also lists 1 research payment totaling $3,770 in 2019.

General payments to Dr. Mirshahidi by program year, 2016 to 2025

General payments to Dr. Mirshahidi by kind, 2016 to 2025

$81.8Kin total
  • Speaker and faculty fees$41,40551%
  • Consulting fees$25,71331%
  • Travel and lodging$7,7229%
  • Food and beverage$3,6254%
  • Other$3,3534%

Companies that paid Dr. Mirshahidi the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Mirshahidi

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Hamid R. Mirshahidi has 3 awards and honors on record

Dmand AI lists 3 awards for Dr. Mirshahidi, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. Mirshahidi

  1. 2013
    • CMS Stage 1 EHR
  2. 2008
    • Best Doctors in Inland Empire
  3. 2005
    • Margaret J. Albrink Research Award

Source: Dmand AI Professional Profile Data

Dr. Hamid R. Mirshahidi graduated from Marmara Univ- Fac Med

Dr. Mirshahidi graduated from Marmara Univ- Fac Med in 1992.

  1. Medical schoolMarmara Univ- Fac Med
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Hamid R. Mirshahidi accepts plans from 17 insurance carriers

Dr. Mirshahidi is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.

  • Elevance
  • Aetna
  • Excellus BlueCross BlueShield
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • HCSC
  • Blue Cross Blue Shield of Massachusetts
  • Molina
  • +9 more carriersWith a free account

Plan types Dr. Mirshahidi accepts, by number of carriers

  1. Medicare10
  2. PPO10
  3. HMO8
  4. POS6
  5. EPO5
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Hamid R. Mirshahidi's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Hamid R. Mirshahidi

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Hamid R. Mirshahidi's NPI number?

Dr. Hamid R. Mirshahidi's NPI number is 1659307015. It was assigned on June 25, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Hamid R. Mirshahidi?

Dr. Hamid R. Mirshahidi is a medical oncologist in Loma Linda, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Hamid R. Mirshahidi practice?

Dr. Mirshahidi practices at 11234 Anderson St, Loma Linda, CA 92354. Dr. Mirshahidi's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. Dmand AI also links Dr. Mirshahidi to 1 group practice or clinic.

What is Dr. Hamid R. Mirshahidi's office phone number?

The practice phone on file for Dr. Mirshahidi is (909) 558-4000.

What is Dr. Hamid R. Mirshahidi's medical license number?

Dr. Mirshahidi holds California license A80969, one of the licenses on file in 3 states.

Which states has Dr. Hamid R. Mirshahidi been licensed in?

Dmand AI has state licenses on file for Dr. Mirshahidi in California (2002 to 2026), Michigan (1999 to 2018) and West Virginia (2002 to 2017).

Which hospitals is Dr. Hamid R. Mirshahidi affiliated with?

Dr. Mirshahidi practices at Loma Linda University Medical Center in Loma Linda, California.

What medical group is Dr. Hamid R. Mirshahidi part of?

Dr. Mirshahidi is linked to Loma Linda University Faculty Medical Group (LLUFMG).

Does Dr. Hamid R. Mirshahidi accept Medicare?

Yes. CMS data shows Dr. Mirshahidi billed Medicare for 979 services in 2024, and Dr. Mirshahidi accepts Medicare assignment.

Does Dr. Hamid R. Mirshahidi offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Mirshahidi as offering telehealth services.

Show 11 more questionsShow fewer questions

What is Dr. Hamid R. Mirshahidi's MIPS score?

Dr. Mirshahidi's MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.

How many Medicare patients does Dr. Hamid R. Mirshahidi see?

CMS counts 234 Medicare patients who saw Dr. Mirshahidi in 2024, with an average age of 72.

Is Dr. Hamid R. Mirshahidi board certified?

Yes. Dr. Mirshahidi is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Hamid R. Mirshahidi bill to Medicare?

In 2024, Dr. Mirshahidi's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and office visit, established patient (99215).

Where did Dr. Hamid R. Mirshahidi go to medical school?

Dr. Mirshahidi graduated from Marmara Univ- Fac Med in 1992.

What drugs does Dr. Hamid R. Mirshahidi prescribe most?

In 2024 Medicare Part D data, Dr. Mirshahidi's most prescribed drugs by claims were Anastrozole, Tagrisso and Letrozole.

Has Dr. Hamid R. Mirshahidi received payments from drug or device companies?

CMS Open Payments shows $81,817 in general payments to Dr. Mirshahidi from 26 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.

How long has Dr. Hamid R. Mirshahidi been practicing?

Dr. Mirshahidi graduated from medical school in 1992, 34 years ago.

Does Dr. Hamid R. Mirshahidi do research?

Dmand AI links 38 publications to Dr. Mirshahidi, published from 2010 to 2025. Dr. Mirshahidi has worked on 8 clinical trials.

Who does Dr. Hamid R. Mirshahidi publish with?

Dr. Mirshahidi's most frequent co-authors are Anthony Loc Nguyen, MD (5 shared papers), David Baylink, MD (2 shared papers) and Joel M. Brothers, MD (2 shared papers).

What insurance does Dr. Hamid R. Mirshahidi accept?

Dr. Mirshahidi is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)